Other News

Cordis, a Cardinal Health Company, introduces innovative products at EUROPCR 2017 to rapidly expand interventional cardiology offering

PCRonline/News/Industry Press Releases – 15 May, 2017 DUBLIN, Ohio. Cordis, Cardinal Health‘s interventional vascular business, announced today the commercial launch of three new products that further enhance its interventional cardiology product portfolio in Europe, the Middle East, and Africa (EMEA). The addition of the Cordis RAILWAY Sheathless Access System as well […]

Occlutech Obtains European CE Mark for its Novel PmVSD Occluder

NEWS PROVIDED BY – Occlutech – 05 Apr, 2017, 07:00 ET SCHAFFHAUSEN, Switzerland, April 5, 2017 /PRNewswire/ — Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a […]

Janssen Collaborates with Premier Inc. on Unique Study to Improve Stroke Risk Management among Hospitalized Patients with Atrial Fibrillation

NEWS PROVIDED BY Janssen Pharmaceuticals, Inc.  | 03 Apr, 2017, 08:00 ET TITUSVILLE, N.J., April 3, 2017 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation […]

InfoBionic Names Industry Veteran Stuart Long Chief Executive Officer

BOSTON, April 4, 2017 /PRNewswire/ — InfoBionic (www.infobionic.com) today announced that Stuart Long was named Chief Executive Officer, underscoring the Company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management. “InfoBionic is redefining the ‘standard of care’ for patients and physicians alike with […]

SoCal’s Endologix Gets $170 Million Injection to Advance Aortic Disorder Treatment

Endologix Enters into $170 Million Credit Facility with Deerfield Management IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has entered into an agreement with Deerfield Management (“Deerfield”), a leading healthcare investment organization, to provide Endologix with up to $170 […]

Essential Medical, Inc., Addressing the Rapidly Growing Large Bore Vascular Closure Market

MALVERN, Pennsylvania, April 3, 2017 /PRNewswire/ — Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced the publication of the MANTA CE marking study results in JACC Interventions titled: “Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access” (http://dx.doi.org/10.1016/j.jcin.2016.12.277). This first, […]

Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements

April 03, 2017 06:00 AM Eastern Daylight Time OXFORDSHIRE, U.K. & SHANGHAI–(BUSINESS WIRE)–Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced the parties have […]

Endologix announces enrolment of first patients in ELEVATE IDE clinical study

Mar 31, 2017 – IRVINE, Calif.–(BUSINESS WIRE)– Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the first patients were treated in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study, the Company’s pivotal clinical trial to […]

Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation

Press Release DUBLIN – March 30, 2017 – Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP Persistent AF clinical trial. The trial will evaluate the safety and effectiveness of a pulmonary vein isolation-only (PVI) strategy for treating patients with persistent atrial fibrillation (AF), using the Arctic Front Advance(TM) Cardiac […]